secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001104659-26-013907
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics special meeting fails due to no quorum; new meeting to seek warrant approval
--------------------------------------------------------------------------------

- Special meeting on Feb 11, 2026 could not convene because a quorum was not present.
- Company will call a new meeting to seek approval to issue up to 16,184,560 shares upon warrant exercise.
- Under Inducement Agreement dated Oct 16, 2025, must call meetings every 60 days until approval or warrants expire.
- New meeting date and proxy materials to be announced later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465926013907/0001104659-26-013907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465926013907/tm266134d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-013907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer